Table 1.
Species | Model | Wnt-related molecule/signaling alterations | ||||
---|---|---|---|---|---|---|
mRNA levels in ALS | Protein levels in ALS | Cellular expression pattern | ||||
WT | ALS | Reference | ||||
Mouse | SOD1G93A | ↑ Wnt1, Wnt2, Wnt3, Wnt3a, Wnt4, Wnt5a, Wnt5b, Wnt7a, Wnt7b, Wnt8a, Wnt9a, Wnt10a, Wnt11, Wnt16, Fz1, Fz2, Fz3, Fz4, Fz5, Fz6, Fz7, Fz8, Fz9, Fz10, LRP5, Wif1, sFRP3 and sFRP4. ↓ Wnt8b, Wnt16, sFRP1 and sFRP3. |
↑ Wnt4 ↑ Wif1 |
Neurons and astrocytes Neurons and astrocytes | ↑ Astrocytes ↓ Neurons ↑ Astrocytes ↓ Neurons |
Yu et al., 2013 |
Mouse | SOD1G93A | ↑ Wnt5a, Wnt7b, Fz1, Fz2, Fz3, Fz8, ROR2 and Wif1 ↓ Wnt4 and Fz4 |
Fz5 NE | Neurons and astrocytes | ↑ Neurons | Gonzalez-Fernandez et al., 2016b |
Mouse | SOD1G93A | ↑ Wnt2 and Wnt7a = GSK-3β | ↑ Wnt2. ↑ Wnt7a ↑ P-GSK-3β |
Neurons and astrocytes Neurons and astrocytes Neurons | ↑ Astrocytes ↑ Astrocytes = |
Chen et al., 2012b |
Mouse | SOD1G93A | ↑ Wnt5a and Fz2 | ↑ Wnt5a ↑ Fz2 |
Neurons and astrocytes Neurons and astrocytes | ↑ Astrocytes ↓ Neurons ↑ Astrocytes ↓ Neurons |
Li et al., 2013 |
Primary cultured astrocytes | NE | ↑ Wnt5a ↑ Fz2 |
||||
NSC34-hSOD1 mutated cells | NE | ↓ Wnt5a ↓ Fz2 |
||||
Mouse | SOD1G93A | ↑ Wnt1 and Fz1 | ↑ Wnt1 ↓ Fz1 |
Neurons and astrocytes Neurons and astrocytes | ↑ Astrocytes ↑ Astrocytes |
Wang et al., 2013 |
Primary cultured astrocytes | NE | ↑ Wnt1 | ||||
N2a-hSOD1 mutated cells | NE | ↓ Wnt1 | ||||
Mouse | SOD1G93A | ↑ Wnt3a and Cyclin D1 | ↑ Wnt3a | Neurons and astrocytes | ↑ Astrocytes ↓ Neurons |
Chen et al., 2012a |
=β-caterin | =β-caterin | Neurons and astrocytes | ↑ Astrocytes ↓ Neurons |
|||
↑ Nuclear β-catenin | ||||||
↑ Cyclin D1 | Neurons and astrocytes | ↑ Astrocytes | ||||
Mouse | SOD1G93A | NE | ↑ aPKC. | Neurons and oligodendrocytes | ↑ Astrocytes | Tury et al., 2014 |
Ryk NE | Neurons and oligodendrocytes | ↑ MNs ↑ Axons |
||||
Mouse | NSC34-hSOD1 mutated cells | NE | ↑β-catenin cytosolic aggregates | Pinto et al., 2013; Pinto et al., 2019 | ||
Human | MNs differentiated from iPSCs derived from ALS patients | ND | ↑ Nuclear β-catenin | Bhinge et al., 2017 | ||
Human | ALS patients | NE | Wnt1 NE Wnt3a NE | Axons Axons | ↑ Axons in EOM compared to LM ↑ Axons in EOM compared to LM |
McLoon et al., 2014 |
Human | ALS patients | ↑ Wnt3, Wnt4, Fz2, and Fz8 | ↑ Wnt5a ↑ Fz2 |
Neurons and astrocytes Neurons and astrocytes | ↑ Astrocytes ↑ Astrocytes |
Gonzalez-Fernandez et al., 2019 |
↑: Upregulation/increase; ↓: downregulation/decrease; =: no changes. ALS: Amyotrophic lateral sclerosis; aPKC: atypical protein kinase C; EOM: extraocular muscles; Fz: Frizzled; GSK-3β: glycogen synthase kinase 3β; hSOD1: human copper-zinc superoxide dismutase; iPSCs: induced pluripotent stem cells; LB: limb muscles; LRP: low-density lipid receptor-related protein; MNs: motor neurons; ND: not detailed; NE: not evaluated; Ryk: receptor-like tyrosine kinase; sFRP: secreted frizzled-related protein; Wif1: Wnt inhibitory factor 1; WT: wild-type.